Prostate Cancer - Results from #2760

Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic review. May 18, 2023

Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond. May 18, 2023

Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study. May 18, 2023

Prognostic role of early prostate specific antigen changes after [177 Lu]Lu-PSMA radioligand therapy of metastasized prostate cancer: A meta-analysis. May 18, 2023

Can 68 Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy? May 17, 2023

A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading. May 17, 2023

Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer. May 17, 2023

Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning. May 17, 2023

Differential Expression of miRNAs Contributes to Tumor Aggressiveness and Racial Disparity in African American Men with Prostate Cancer. May 17, 2023

Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up. May 16, 2023

Management of Advanced Prostate Cancer in the Precision Oncology Era. May 16, 2023

A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer. May 16, 2023

Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study. May 16, 2023

Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer. May 16, 2023

Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy. May 16, 2023

Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance. May 16, 2023

Extensive 177Lu-PSMA Radioligand Therapy Can Lead to Radiation Nephropathy with a Renal Thrombotic Microangiopathy-like Picture. May 15, 2023

Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy. May 15, 2023

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer. May 15, 2023

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer. May 15, 2023

Page 139 of 1439